FIELD: pharmacology.
SUBSTANCE: invention refers to medicine, specifically to a new chemical compound - 3-hydroxypyridine derivative of formula
expressing anti-ischemic, cerebroprotective, neurotropic and lipid-regulating activity, and to solid and liquid pharmaceutical compositions based thereon, and to application in manufacturing of medical products for prevention and treatment of cardiovascular, mental diseases, cerebral ischemia and obesity.
EFFECT: new compound which can be perspective in manufacturing of medical products for prevention and treatment of cardiovascular, mental diseases, cerebral ischemia and obesity.
12 cl, 11 ex, 16 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT EXHIBITING HEPATOPROTECTIVE, LIPID-REGULATING, ANTIISCHEMIC AND NEUROTROPIC ACTIVITY | 2018 |
|
RU2705575C1 |
| NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
| DERIVATIVE OF IMIDAZO-[1,2A]-BENZIMIDAZOLE - AGENT PRODUCING CEREBROPROTECTIVE EFFECT IN RADIATION INJURES | 2001 |
|
RU2238938C2 |
| 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE AND NICOTINIC ACID SALT, HAVING HYPOGLYCEMIC, HYPOLIPIDEMIC AND NEUROPROTECTIVE ACTIVITY AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2454406C2 |
| NEUROPROTECTOR | 2004 |
|
RU2268715C1 |
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
| BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
| DISODIUM SALT OF 3-HYDROXYHIPPURIC ACID, HAVING ANTIHYPOXIC AND CEREBROPROTECTIVE ACTION | 2014 |
|
RU2559875C1 |
